Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL)
NYSEARCA: PILL · Real-Time Price · USD
19.01
-0.19 (-0.99%)
Jul 24, 2026, 12:46 PM EDT - Market open
-0.99% (1D)
| Assets | $20.79M |
| Expense Ratio | 0.98% |
| PE Ratio | n/a |
| Shares Out | 1.10M |
| Dividend (ttm) | $0.07 |
| Dividend Yield | 0.36% |
| Ex-Dividend Date | Jun 23, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| Volume | 20,431 |
| Open | 19.21 |
| Previous Close | 19.20 |
| Day's Range | 18.48 - 19.50 |
| 52-Week Low | 5.20 |
| 52-Week High | 21.03 |
| Beta | 1.72 |
| Holdings | 76 |
| Inception Date | Nov 15, 2017 |
About PILL
Fund Home PageThe Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is issued by Direxion.
Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol PILL
ETF Provider Direxion
Index Tracked S&P Pharmaceuticals Select Industry
Top 10 Holdings
60.29% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Finl Sq Trsry Inst 506 | n/a | 23.58% |
| S&P Pharmaceuticals Select Index Swap | n/a | 15.48% |
| S&P Pharmaceuticals Select Index Swap | n/a | 7.31% |
| Crinetics Pharmaceuticals, Inc. | CRNX | 2.64% |
| Definium Therapeutics, Inc. | DFTX | 2.12% |
| MBX Biosciences, Inc. | MBX | 2.11% |
| S&P Pharmaceuticals Select Index Swap | n/a | 2.00% |
| Dreyfus Govt Cash Man Ins | n/a | 1.93% |
| Enliven Therapeutics, Inc. | ELVN | 1.55% |
| Alumis Inc. | ALMS | 1.55% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 23, 2026 | $0.01517 | Jun 30, 2026 |
| Mar 24, 2026 | $0.01085 | Mar 31, 2026 |
| Dec 23, 2025 | $0.03265 | Dec 31, 2025 |
| Sep 23, 2025 | $0.00985 | Sep 30, 2025 |
| Jun 24, 2025 | $0.02449 | Jul 1, 2025 |
| Mar 25, 2025 | $0.01829 | Apr 1, 2025 |
Performance
PILL had a total return of 229.05% in the past year, including dividends. Since the fund's inception, the average annual return has been -1.55%.
News
Top Performing Leveraged/Inverse ETFs: 06/14/2026
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
5 weeks ago - ETF Trends